2nd Quarter - Report

THE MCMANUS GROUP for AMGEN

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Part B drug reimbursement, including implementation of bundled payment for dialysis. Medicare Part D issues.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
NICK SHIPLEY Legislative Director, Rep. Jay Inslee

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Implementation of Health Care Reform PL 111-148 Patient Protection and Affordable Care Act (Biosimilars, IPAB). Issues relating to S.3187, Food and Drug Administration Safety and Innovation Act.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
NICK SHIPLEY Legislative Director, Rep. Jay Inslee

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3187 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.